The role of magnetic resonance imaging in targeting prostate cancer in patients with previous negative biopsies and elevated prostate-specific antigen levels

BJU International

Volumn 103, Issue 6, 2009, Pages 730-733

  Lawrentschuk, Nathan ^b   Fleshner, Neil ^a,b  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Biopsy; Diagnostic imaging; MRI; Prostatic neoplasms; Review

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ARTICLE; CANCER DIAGNOSIS; COMPARATIVE STUDY; COST BENEFIT ANALYSIS; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; SENSITIVITY AND SPECIFICITY; TUMOR BIOPSY;

BIOPSY; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 61349142372     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2008.08205.x     Document Type: Article

References (33)

1. Kirkham AP, Emberton M, Allen C. How good is MRI at detecting and characterising cancer within the prostate? Eur Urol 2006 50 : 1163 74
2. NCCN. NCCN Practice Guidelines in Prostate Cancer. Fort Washington, PA : National Comprehensive Cancer Network, 2007
3. Shukla-Dave A, Hricak H, Scardino PT. Imaging low-risk prostate cancer. Curr Opin Urol 2008 18 : 78 86
4. Sonnad SS, Langlotz CP, Schwartz JS. Accuracy of MR imaging for staging prostate cancer: a meta-analysis to examine the effect of technologic change. Acad Radiol 2001 8 : 149 57
5. Rovner ES, Schanne FJ, Malkowicz SB et al. Transurethral biopsy of the prostate for persistently elevated or increasing prostate specific antigen following multiple negative transrectal biopsies. J Urol 1997 158 : 138 41
6. Lane BR, Zippe CD, Abouassaly R et al. Saturation technique does not decrease cancer detection during followup after initial prostate biopsy. J Urol 2008 179 : 1746 50
7. Scattoni V, Zlotta A, Montironi R et al. Extended and saturation prostatic biopsy in the diagnosis and characterisation of prostate cancer: a critical analysis of the literature. Eur Urol 2007 52 : 1309 22
8. Cirillo S, Petracchini M, Della Monica P et al. Value of endorectal MRI and MRS in patients with elevated prostate-specific antigen levels and previous negative biopsies to localize peripheral zone tumours. Clin Radiol 2008 63 : 871 9
9. Amsellem-Ouazana D, Younes P, Conquy S et al. Negative prostatic biopsies in patients with a high risk of prostate cancer. Is the combination of endorectal MRI and magnetic resonance spectroscopy imaging (MRSI) a useful tool? A preliminary study. Eur Urol 2005 47 : 582 6
10. Prando A, Kurhanewicz J, Borges AP et al. Prostatic biopsy directed with endorectal MR spectroscopic imaging findings in patients with elevated prostate specific antigen levels and prior negative biopsy findings: early experience. Radiology 2005 236 : 903 10
11. Beyersdorff D, Taupitz M, Winkelmann B et al. Patients with a history of elevated prostate-specific antigen levels and negative transrectal US-guided quadrant or sextant biopsy Results: value of MR imaging. Radiology 2002 224 : 701 6
12. Yuen JS, Thng CH, Tan PH et al. Endorectal magnetic resonance imaging and spectroscopy for the detection of tumor foci in men with prior negative transrectal ultrasound prostate biopsy. J Urol 2004 171 : 1482 6
13. Schnall MD, Lenkinski RE, Pollack HM et al. Prostate: MR imaging with an endorectal surface coil. Radiology 1989 172 : 570 4
14. Rorvik J, Haukaas S. Magnetic resonance imaging of the prostate. Curr Opin Urol 2001 11 : 181 8
15. Hering F, Muller S. 31P MR spectroscopy and 1H MR imaging of the human prostate using a transrectal probe. Urol Res 1991 19 : 349 52
16. Beyersdorff D, Taymoorian K, Knosel T et al. MRI of prostate cancer at 1.5 and 3.0 T: comparison of image quality in tumor detection and staging. AJR Am J Roentgenol 2005 185 : 1214 20
17. Perrotti M, Han KR, Epstein RE et al. Prospective evaluation of endorectal magnetic resonance imaging to detect tumor foci in men with prior negative prostatic biopsy: a pilot study. J Urol 1999 162 : 1314 7
18. Biondetti PR, Lee JK, Ling D et al. Clinical stage B prostate carcinoma: staging with MR imaging. Radiology 1987 162 : 325 9
19. Bockisch A, Jager N, Biersack HJ et al. Magnetic resonance (MR) imaging of prostatic tumours, a comparison with X-ray CT and transrectal sonography (TRS). Eur J Radiol 1988 8 : 54 9
20. Steyn JH, Smith FW. Nuclear magnetic resonance imaging of the prostate. Br J Urol 1982 54 : 726 8
21. Chang PJ. Evaluating the role of transrectal ultrasonography and magnetic resonance imaging in prostate carcinoma. Curr Opin Radiol 1991 3 : 687 93
22. Djavan B, Ravery V, Zlotta A et al. Prospective evaluation of prostate cancer detected on biopsies 1, 2, 3 and 4: when should we stop? J Urol 2001 166 : 1679 83
23. Stav K, Leibovici D, Sandbank J et al. Saturation prostate biopsy in high risk patients after multiple previous negative biopsies. Urology 2008 71 : 399 403
24. Finne P, Auvinen A, Maattanen L et al. Diagnostic value of free prostate-specific antigen among men with a prostate-specific antigen level of <3.0 mug per liter. Eur Urol 2008 54 : 362 70
25. Ashley RA, Inman BA, Routh JC et al. Reassessing the diagnostic yield of saturation biopsy of the prostate. Eur Urol 2008 53 : 976 81
26. Barzell WE, Melamed MR. Appropriate patient selection in the focal treatment of prostate cancer: the role of transperineal 3-dimensional pathologic mapping of the prostate - a 4-year experience. Urology 2007 70 : 27 35
27. Ellis JH, Tempany C, Sarin MS et al. MR imaging and sonography of early prostatic cancer: pathologic and imaging features that influence identification and diagnosis. AJR Am J Roentgenol 1994 162 : 865 72
28. Padhani AR, Gapinski CJ, Macvicar DA et al. Dynamic contrast enhanced MRI of prostate cancer: correlation with morphology and tumour stage, histological grade and PSA. Clin Radiol 2000 55 : 99 109
29. Sommer FG, McNeal JE, Carrol CL. MR depiction of zonal anatomy of the prostate at 1.5 T. J Comput Assist Tomogr 1986 10 : 983 9
30. Akin O, Sala E, Moskowitz CS et al. Transition zone prostate cancers: features, detection, localization, and staging at endorectal MR imaging. Radiology 2006 239 : 784 92
31. Al-Ahmadie HA, Tickoo SK, Olgac S et al. Anterior-predominant prostatic tumors: zone of origin and pathologic outcomes at radical prostatectomy. Am J Surg Pathol 2008 32 : 229 35
32. Albertsen PC, Hanley JA, Barrows GH et al. Prostate cancer and the Will Rogers phenomenon. J Natl Cancer Inst 2005 97 : 1248 53
33. Cabrera AR, Coakley FV, Westphalen AC et al. Prostate cancer: is inapparent tumor at endorectal MR and MR spectroscopic imaging a favorable prognostic finding in patients who select active surveillance? Radiology 2008 247 : 444 50